Association between ethnicity, language and metformin prescriptions in U.S. community health center patients with diabetes
Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites,...
Saved in:
| Published in | Preventive medicine Vol. 185; p. 108025 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.08.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0091-7435 1096-0260 1096-0260 |
| DOI | 10.1016/j.ypmed.2024.108025 |
Cover
| Abstract | Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes.
We constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results.
English-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)).
Our analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients.
•Metformin prescriptions at US health centers are similar between Latinos and whites.•Spanish-speaking Latinos are prescribed more than English-speaking Latinos.•Time to metformin prescription from diabetes diagnosis is not worse in Latinos |
|---|---|
| AbstractList | AbstractBackgroundMetformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes. MethodsWe constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results. ResultsEnglish-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)). ConclusionsOur analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients. Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes. We constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results. English-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)). Our analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients. Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes. We constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results. English-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)). Our analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients. •Metformin prescriptions at US health centers are similar between Latinos and whites.•Spanish-speaking Latinos are prescribed more than English-speaking Latinos.•Time to metformin prescription from diabetes diagnosis is not worse in Latinos Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes.BACKGROUNDMetformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their level of diabetes care, including medication prescription. We evaluated the odds of and times to metformin prescription among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos with diabetes.We constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results.METHODSWe constructed a retrospective cohort of 154,368 adult patients from 835 community health centers (CHCs) across 20 states who were diagnosed with diabetes during the study. Patients were from non-Latino white, English-preferring Latino, and Spanish-preferring Latino ethnic/language groups. We modeled adjusted odds of metformin prescription and adjusted hazards (time-to-event) of metformin prescription after diabetes diagnosis and high hemoglobin A1c (HbA1c > 9) test results.English-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)).RESULTSEnglish-preferring Latinos had similar odds of metformin prescription (Odds Ratio (OR) = 1.01 (95% CI = 0.93, 1.09)), slightly lower time to metformin prescription after diabetes diagnosis (Hazard Ratio (HR) = 1.06(95% CI = 1.04, 1.09)), and similar time to metformin prescription after a high HbA1c result (HR = 1.04 (0.99, 1.09)) compared to non-Latino whites. Spanish-preferring Latinos had higher odds of metformin prescription (OR) = 1.42 (95% CI = 1.33, 1.52), and less time to prescription after diabetes diagnosis (HR = 1.18 (1.15, 1.20)) and after a high HbA1c result (HR = 1.15 (1.11, 1.20)).Our analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients.CONCLUSIONSOur analysis of metformin prescription patterns among non-Latino whites, English-preferring Latinos, and Spanish-preferring Latinos did not suggest a lower or slower tendency to prescribe metformin in Latino patients. Understanding disparities in diabetes diagnosis may require further investigation of medication adherence barriers, diet and exercise counseling, and multi-level influences on diabetes outcomes in Latino patients. |
| ArticleNumber | 108025 |
| Author | Boston, Dave Aceves, Benjamín Marino, Miguel Datta, Roopradha Heintzman, John Ezekiel-Herrera, David Lucas, Jennifer A. |
| AuthorAffiliation | 3 OCHIN, Inc. Portland, OR, USA 1 Oregon Health & Science University Department of Family Medicine, Portland, OR, USA 2 San Diego State University School of Public Health, San Diego, CA, USA |
| AuthorAffiliation_xml | – name: 2 San Diego State University School of Public Health, San Diego, CA, USA – name: 1 Oregon Health & Science University Department of Family Medicine, Portland, OR, USA – name: 3 OCHIN, Inc. Portland, OR, USA |
| Author_xml | – sequence: 1 givenname: David surname: Ezekiel-Herrera fullname: Ezekiel-Herrera, David email: ezekiel@ohsu.edu organization: Oregon Health & Science University Department of Family Medicine, Portland, OR, USA – sequence: 2 givenname: Miguel surname: Marino fullname: Marino, Miguel organization: Oregon Health & Science University Department of Family Medicine, Portland, OR, USA – sequence: 3 givenname: Jennifer A. surname: Lucas fullname: Lucas, Jennifer A. organization: Oregon Health & Science University Department of Family Medicine, Portland, OR, USA – sequence: 4 givenname: Roopradha surname: Datta fullname: Datta, Roopradha organization: Oregon Health & Science University Department of Family Medicine, Portland, OR, USA – sequence: 5 givenname: Benjamín surname: Aceves fullname: Aceves, Benjamín organization: San Diego State University School of Public Health, San Diego, CA, USA – sequence: 6 givenname: Dave surname: Boston fullname: Boston, Dave organization: OCHIN, Inc., Portland, OR, USA – sequence: 7 givenname: John surname: Heintzman fullname: Heintzman, John organization: Oregon Health & Science University Department of Family Medicine, Portland, OR, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38834161$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUl1v1DAQtFARvRZ-ARLyIw8k2I4vOQsBqiq-pEo8lD5bjrO585HYwU5aHb-ezV2LoBLUL7Z2d2asmT0hRz54IOQ5ZzlnvHy9zXdDD00umJBYWTGxfEQWnKkyY6JkR2TBmOJZJYvlMTlJacsY5yWTT8hxsVoVkpd8QX6epRSsM6MLntYw3gB4CuPGO-vG3SvaGb-ezBqo8Q3tYWxD7J2nQ4RkoxtmWKJYuMovc2pD308ecXQDphs31IIfIdIB6fGV6I3DYuMMCkF6Sh63pkvw7PY-JVcfP3w7_5xdfP305fzsIrOyqMZMqKVpBKtbU_G6FGolCzxG8aotRStVLdqmKlUDpqkbgNaI2lrOJLB6bqrilLw_8A5TjX7Nf4qm00N0vYk7HYzTf3e82-h1uNacF7IsFEeGl7cMMfyYII26d8lCh-ZAmJIuWCmV4EsmcfTFn2K_Ve4cxwF1GLAxpBSh1Wj03n7Udp3mTM_p6q3ep6vndPUhXcQW97B39P9HvT2gAE2-dhB1shiHhcZFsKNugnsA_-4e3nYO98N032EHaRum6DE_zXUSmunLeevmpRMSF2619-TNvwkelP8FgITrlQ |
| CitedBy_id | crossref_primary_10_1093_haschl_qxae178 |
| Cites_doi | 10.1007/s10903-011-9456-7 10.1016/S0140-6736(06)69420-8 10.1016/j.amepre.2021.07.009 10.1056/NEJMoa012512 10.1002/dmrr.3097 10.2337/dc08-1234 10.1016/j.ypmed.2023.107657 10.1016/j.diabres.2020.108531 10.2337/cd23-as01 10.7326/0003-4819-142-5-200503010-00007 10.2337/dc09-0341 10.3122/jabfm.2011.05.110052 10.1007/s10903-019-00867-9 10.1016/j.cct.2015.10.011 10.1002/phar.1772 10.1016/S0140-6736(02)08905-5 10.3122/jabfm.2013.03.120234 10.1016/j.focus.2023.100077 |
| ContentType | Journal Article |
| Copyright | 2024 Elsevier Inc. Copyright © 2024 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2024 Elsevier Inc. – notice: Copyright © 2024 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.ypmed.2024.108025 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1096-0260 |
| EndPage | 108025 |
| ExternalDocumentID | PMC11346391 38834161 10_1016_j_ypmed_2024_108025 S0091743524001804 1_s2_0_S0091743524001804 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NIMHD NIH HHS grantid: R01 MD014120 |
| GroupedDBID | --- --K --M -ET .1- .55 .FO .GJ .~1 0R~ 123 1B1 1CY 1P~ 1RT 1~. 1~5 29O 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN ADXHL AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AI2 AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IH2 IHE J1W KOM LG5 LZ2 M29 M41 MO0 N4W N9A O-L O9- OAUVE OD~ OHT OO0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K TWZ UNMZH VJK WUQ X7M XPP Z5R ZGI ZMT ZU3 ~G- ~KM 0SF AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ PKN RIG AAYXX ACLOT CITATION EFLBG ~HD AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c437t-295ad20bfa71b629843333a917f62f49b2fd769deadbdeefa2bcc104e0b49b293 |
| IEDL.DBID | .~1 |
| ISSN | 0091-7435 1096-0260 |
| IngestDate | Tue Sep 30 17:02:43 EDT 2025 Wed Oct 01 17:15:58 EDT 2025 Sun Aug 03 01:52:45 EDT 2025 Thu Apr 24 23:07:10 EDT 2025 Wed Oct 01 03:30:39 EDT 2025 Sun Apr 06 06:53:42 EDT 2025 Tue Feb 25 20:09:54 EST 2025 Tue Aug 26 16:33:28 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Diabetes Metformin Community health centers Health disparities |
| Language | English |
| License | Copyright © 2024 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c437t-295ad20bfa71b629843333a917f62f49b2fd769deadbdeefa2bcc104e0b49b293 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author Contributions: DEH conceptualized and designed the study, drafted the initial manuscript, created the analytic dataset, analyzed the data, and reviewed and revised the manuscript. MM and JH conceptualized and designed the study, helped interpret findings, and reviewed and revised the manuscript. JAL, RD, BA, and DB helped interpret findings, and reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. |
| ORCID | 0000-0002-2895-9809 0000-0002-2005-8344 |
| PMID | 38834161 |
| PQID | 3064921504 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11346391 proquest_miscellaneous_3064921504 pubmed_primary_38834161 crossref_citationtrail_10_1016_j_ypmed_2024_108025 crossref_primary_10_1016_j_ypmed_2024_108025 elsevier_sciencedirect_doi_10_1016_j_ypmed_2024_108025 elsevier_clinicalkeyesjournals_1_s2_0_S0091743524001804 elsevier_clinicalkey_doi_10_1016_j_ypmed_2024_108025 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-01 |
| PublicationDateYYYYMMDD | 2024-08-01 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Preventive medicine |
| PublicationTitleAlternate | Prev Med |
| PublicationYear | 2024 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Rhee, Herrick, Ziemer (bb0105) Jan 2010; 33 American Diabetes A (bb0015) 2022; 41 Chan, Ezekiel-Herrera, Bailey (bb0025) 2023; 2 Soric, Moorman, Boyle, Dengler-Crish (bb0115) Jul 2016; 36 Corcoran, Jacobs (bb0040) 2023 Aceves, Ezekiel-Herrera, Marino (bb0005) Apr 2022; 26 Herman, Hoerger, Brandle (bb0070) Mar 1 2005; 142 Oh, Dodd, Ballard-Barbash, Perna, Berrigan (bb0090) Oct 2011; 13 Gerstein, Yusuf, Bosch (bb0055) Sep 23 2006; 368 Heintzman, Ezekiel-Herrera, Quiñones (bb0060) Feb 2022; 62 Heintzman, Hodes, Parras (bb0065) 2023; 175 Knowler, Barrett-Connor, Fowler (bb0075) Feb 7 2002; 346 Chiasson, Josse, Gomis, Hanefeld, Karasik, Laakso (bb0030) Jun 15 2002; 359 Committee ADAPP (bb0035) Jan 01 2024; 47 Baghikar, Benitez, Fernandez Piñeros, Gao, Baig (bb0020) 2019; 21 National Association of Community Health Centers. Community Health Center Chartbook. NACHC. Devoe, Gold, Spofford (bb0050) 2011; 24 Devoe, Sears (bb0045) 2013; 26 . Ruelas, Roybal, Lu, Goldman, Peters (bb0110) 2009; 32 Aguayo-Mazzucato, Diaque, Hernandez, Rosas, Kostic, Caballero (bb0010) 2019; 35 Perez, Alos, Scanlan (bb0095) 2015; 45 Mahabaleshwarkar, DeSantis (bb0080) Feb 2021; 172 Prevention CfDCa (bb0100) 2023 What is a Community Health Center? National Association of Community Health Centers. Accessed May 14, 2024 Committee ADAPP (10.1016/j.ypmed.2024.108025_bb0035) 2024; 47 Mahabaleshwarkar (10.1016/j.ypmed.2024.108025_bb0080) 2021; 172 Ruelas (10.1016/j.ypmed.2024.108025_bb0110) 2009; 32 Devoe (10.1016/j.ypmed.2024.108025_bb0045) 2013; 26 Soric (10.1016/j.ypmed.2024.108025_bb0115) 2016; 36 Herman (10.1016/j.ypmed.2024.108025_bb0070) 2005; 142 Prevention CfDCa (10.1016/j.ypmed.2024.108025_bb0100) 2023 Baghikar (10.1016/j.ypmed.2024.108025_bb0020) 2019; 21 Gerstein (10.1016/j.ypmed.2024.108025_bb0055) 2006; 368 Aguayo-Mazzucato (10.1016/j.ypmed.2024.108025_bb0010) 2019; 35 Knowler (10.1016/j.ypmed.2024.108025_bb0075) 2002; 346 Oh (10.1016/j.ypmed.2024.108025_bb0090) 2011; 13 Perez (10.1016/j.ypmed.2024.108025_bb0095) 2015; 45 Rhee (10.1016/j.ypmed.2024.108025_bb0105) 2010; 33 Chiasson (10.1016/j.ypmed.2024.108025_bb0030) 2002; 359 Heintzman (10.1016/j.ypmed.2024.108025_bb0060) 2022; 62 Heintzman (10.1016/j.ypmed.2024.108025_bb0065) 2023; 175 American Diabetes A (10.1016/j.ypmed.2024.108025_bb0015) 2022; 41 10.1016/j.ypmed.2024.108025_bb0085 Aceves (10.1016/j.ypmed.2024.108025_bb0005) 2022; 26 Devoe (10.1016/j.ypmed.2024.108025_bb0050) 2011; 24 10.1016/j.ypmed.2024.108025_bb0120 Chan (10.1016/j.ypmed.2024.108025_bb0025) 2023; 2 Corcoran (10.1016/j.ypmed.2024.108025_bb0040) 2023 |
| References_xml | – volume: 24 start-page: 597 year: 2011 end-page: 604 ident: bb0050 article-title: Developing a network of community health centers with a common electronic health record: description of the safety net west practice-based research network (SNW-PBRN) publication-title: J. Am. Board Fam. Med. – volume: 359 start-page: 2072 year: Jun 15 2002 end-page: 2077 ident: bb0030 article-title: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial publication-title: Lancet – volume: 142 start-page: 323 year: Mar 1 2005 end-page: 332 ident: bb0070 article-title: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance publication-title: Ann. Intern. Med. – volume: 35 year: 2019 ident: bb0010 article-title: Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States publication-title: Diabetes Metab. Res. Rev. – volume: 33 start-page: 49 year: Jan 2010 end-page: 54 ident: bb0105 article-title: Many Americans have pre-diabetes and should be considered for metformin therapy publication-title: Diabetes Care – volume: 32 start-page: 54 year: 2009 end-page: 56 ident: bb0110 article-title: Clinical and behavioral correlates of achieving and maintaining glycemic targets in an underserved population with type 2 diabetes publication-title: Diabetes Care – volume: 368 start-page: 1096 year: Sep 23 2006 end-page: 1105 ident: bb0055 article-title: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial publication-title: Lancet – volume: 45 start-page: 320 year: 2015 end-page: 327 ident: bb0095 article-title: The rationale, design, and baseline characteristics of PREVENT-DM: a community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes publication-title: Contemp. Clin. Trials – reference: National Association of Community Health Centers. Community Health Center Chartbook. NACHC. – year: 2023 ident: bb0100 article-title: National Diabetes Statistics Report Website – reference: What is a Community Health Center? National Association of Community Health Centers. Accessed May 14, 2024, – volume: 21 start-page: 1334 year: 2019 end-page: 1341 ident: bb0020 article-title: Factors impacting adherence to diabetes medication among urban, low income Mexican-Americans with diabetes publication-title: J. Immigr. Minor. Health – volume: 41 start-page: 4 year: 2022 end-page: 31 ident: bb0015 article-title: Standards of care in diabetes—2023 abridged for primary care providers publication-title: Clin. Diabetes – reference: . – volume: 2 start-page: 100077 year: 2023 ident: bb0025 article-title: Screening for hepatitis C among community health center patients by ethnicity and language preference publication-title: AJPM Focus. – volume: 175 start-page: 107657 year: 2023 ident: bb0065 article-title: The role of language in mammography orders among low-income Latinas over a 10-year period publication-title: Prev. Med. – volume: 13 start-page: 849 year: Oct 2011 end-page: 859 ident: bb0090 article-title: Language use and adherence to multiple cancer preventive health behaviors among Hispanics publication-title: J. Immigr. Minor. Health – volume: 26 year: Apr 2022 ident: bb0005 article-title: Disparities in HbA1c testing between aging US Latino and non-Latino white primary care patients publication-title: Prev. Med. Rep. – year: 2023 ident: bb0040 article-title: Metformin publication-title: . StatPearls Publishing Copyright © 2023 – volume: 26 start-page: 271 year: 2013 end-page: 278 ident: bb0045 article-title: The OCHIN community information network: bringing together community health centers, information technology, and data to support a patient-centered medical village publication-title: J. Am. Board Fam. Med. – volume: 36 start-page: 715 year: Jul 2016 end-page: 722 ident: bb0115 article-title: Prevalence and predictors of metformin prescribing in adults with type 2 diabetes mellitus: a national cross-sectional study publication-title: Pharmacotherapy – volume: 172 year: Feb 2021 ident: bb0080 article-title: Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States publication-title: Diabetes Res. Clin. Pract. – volume: 346 start-page: 393 year: Feb 7 2002 end-page: 403 ident: bb0075 article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin publication-title: N. Engl. J. Med. – volume: 62 start-page: 203 year: Feb 2022 end-page: 210 ident: bb0060 article-title: Disparities in colorectal cancer screening in latinos and non-hispanic whites publication-title: Am. J. Prev. Med. – volume: 47 start-page: S158 year: Jan 01 2024 end-page: S178 ident: bb0035 article-title: 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024 publication-title: Diabetes Care – volume: 13 start-page: 849 issue: 5 year: 2011 ident: 10.1016/j.ypmed.2024.108025_bb0090 article-title: Language use and adherence to multiple cancer preventive health behaviors among Hispanics publication-title: J. Immigr. Minor. Health doi: 10.1007/s10903-011-9456-7 – volume: 368 start-page: 1096 issue: 9541 year: 2006 ident: 10.1016/j.ypmed.2024.108025_bb0055 article-title: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(06)69420-8 – year: 2023 ident: 10.1016/j.ypmed.2024.108025_bb0100 – volume: 62 start-page: 203 issue: 2 year: 2022 ident: 10.1016/j.ypmed.2024.108025_bb0060 article-title: Disparities in colorectal cancer screening in latinos and non-hispanic whites publication-title: Am. J. Prev. Med. doi: 10.1016/j.amepre.2021.07.009 – ident: 10.1016/j.ypmed.2024.108025_bb0085 – volume: 346 start-page: 393 issue: 6 year: 2002 ident: 10.1016/j.ypmed.2024.108025_bb0075 article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa012512 – volume: 35 issue: 2 year: 2019 ident: 10.1016/j.ypmed.2024.108025_bb0010 article-title: Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States publication-title: Diabetes Metab. Res. Rev. doi: 10.1002/dmrr.3097 – year: 2023 ident: 10.1016/j.ypmed.2024.108025_bb0040 article-title: Metformin – volume: 32 start-page: 54 issue: 1 year: 2009 ident: 10.1016/j.ypmed.2024.108025_bb0110 article-title: Clinical and behavioral correlates of achieving and maintaining glycemic targets in an underserved population with type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc08-1234 – volume: 175 start-page: 107657 year: 2023 ident: 10.1016/j.ypmed.2024.108025_bb0065 article-title: The role of language in mammography orders among low-income Latinas over a 10-year period publication-title: Prev. Med. doi: 10.1016/j.ypmed.2023.107657 – volume: 26 year: 2022 ident: 10.1016/j.ypmed.2024.108025_bb0005 article-title: Disparities in HbA1c testing between aging US Latino and non-Latino white primary care patients publication-title: Prev. Med. Rep. – volume: 47 start-page: S158 issue: Suppl. 1 year: 2024 ident: 10.1016/j.ypmed.2024.108025_bb0035 article-title: 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024 publication-title: Diabetes Care – volume: 172 year: 2021 ident: 10.1016/j.ypmed.2024.108025_bb0080 article-title: Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2020.108531 – volume: 41 start-page: 4 issue: 1 year: 2022 ident: 10.1016/j.ypmed.2024.108025_bb0015 article-title: Standards of care in diabetes—2023 abridged for primary care providers publication-title: Clin. Diabetes doi: 10.2337/cd23-as01 – volume: 142 start-page: 323 issue: 5 year: 2005 ident: 10.1016/j.ypmed.2024.108025_bb0070 article-title: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-142-5-200503010-00007 – volume: 33 start-page: 49 issue: 1 year: 2010 ident: 10.1016/j.ypmed.2024.108025_bb0105 article-title: Many Americans have pre-diabetes and should be considered for metformin therapy publication-title: Diabetes Care doi: 10.2337/dc09-0341 – volume: 24 start-page: 597 issue: 5 year: 2011 ident: 10.1016/j.ypmed.2024.108025_bb0050 article-title: Developing a network of community health centers with a common electronic health record: description of the safety net west practice-based research network (SNW-PBRN) publication-title: J. Am. Board Fam. Med. doi: 10.3122/jabfm.2011.05.110052 – volume: 21 start-page: 1334 issue: 6 year: 2019 ident: 10.1016/j.ypmed.2024.108025_bb0020 article-title: Factors impacting adherence to diabetes medication among urban, low income Mexican-Americans with diabetes publication-title: J. Immigr. Minor. Health doi: 10.1007/s10903-019-00867-9 – ident: 10.1016/j.ypmed.2024.108025_bb0120 – volume: 45 start-page: 320 year: 2015 ident: 10.1016/j.ypmed.2024.108025_bb0095 article-title: The rationale, design, and baseline characteristics of PREVENT-DM: a community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes publication-title: Contemp. Clin. Trials doi: 10.1016/j.cct.2015.10.011 – volume: 36 start-page: 715 issue: 7 year: 2016 ident: 10.1016/j.ypmed.2024.108025_bb0115 article-title: Prevalence and predictors of metformin prescribing in adults with type 2 diabetes mellitus: a national cross-sectional study publication-title: Pharmacotherapy doi: 10.1002/phar.1772 – volume: 359 start-page: 2072 issue: 9323 year: 2002 ident: 10.1016/j.ypmed.2024.108025_bb0030 article-title: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(02)08905-5 – volume: 26 start-page: 271 issue: 3 year: 2013 ident: 10.1016/j.ypmed.2024.108025_bb0045 article-title: The OCHIN community information network: bringing together community health centers, information technology, and data to support a patient-centered medical village publication-title: J. Am. Board Fam. Med. doi: 10.3122/jabfm.2013.03.120234 – volume: 2 start-page: 100077 issue: 2 year: 2023 ident: 10.1016/j.ypmed.2024.108025_bb0025 article-title: Screening for hepatitis C among community health center patients by ethnicity and language preference publication-title: AJPM Focus. doi: 10.1016/j.focus.2023.100077 |
| SSID | ssj0011604 |
| Score | 2.4463642 |
| Snippet | Metformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may modify their... AbstractBackgroundMetformin treatment is a recommended first-line medication for patients with type 2 diabetes. Latino patients are subject to factors that may... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 108025 |
| SubjectTerms | Adult Aged Community Health Centers Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - ethnology Drug Prescriptions - statistics & numerical data Ethnicity Female Glycated Hemoglobin - analysis Health disparities Hispanic or Latino Humans Hypoglycemic Agents - therapeutic use Internal Medicine Language Male Metformin Metformin - therapeutic use Middle Aged Retrospective Studies United States White |
| Title | Association between ethnicity, language and metformin prescriptions in U.S. community health center patients with diabetes |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091743524001804 https://www.clinicalkey.es/playcontent/1-s2.0-S0091743524001804 https://dx.doi.org/10.1016/j.ypmed.2024.108025 https://www.ncbi.nlm.nih.gov/pubmed/38834161 https://www.proquest.com/docview/3064921504 https://pubmed.ncbi.nlm.nih.gov/PMC11346391 |
| Volume | 185 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1096-0260 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1096-0260 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1096-0260 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: ACRLP dateStart: 20141101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection customDbUrl: eissn: 1096-0260 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: AIKHN dateStart: 20141101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1096-0260 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0011604 issn: 0091-7435 databaseCode: AKRWK dateStart: 19720301 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUQlapKVdXSrwWKXKlHssSO48RHhEDbVnBpV-Jm2bEttqJhRcJhe-C344ntiC2ISs0xsRPHMx7P2G-eEfqiBDOuLE2mnGkyxnKTAal65ow1RvO64SUkCp-e8dmcfTsvzzfQUcqFAVhltP3Bpg_WOt45iL15sFwsIMdXgDtdAgqS1AMnKLB_eZ2e3o4wD0J4HpiYBcmgdGIeGjBeq6WfcnyQSNmAtYPzsh-fnR56n3-DKO_NSiev0avoTuLD0OI3aMO2W-j5adww30Ivw7IcDtlGb9Gfe-LAEaOFbX_R-vL9ah-n5UusWoN_2x5c2kWLAS2bzEuH_Y359McUNyG5pF_hkE2JoZH2Gkeu1g7DIi9Oq7vv0Pzk-OfRLIvHL2QNK6o-o6JUhubaqYpoTkXNCn8p3-mOU8eEps5UXBivi9pY6xTVTeOjO5treCiK92izvWrtR4R1qUuiLCl1LVjDKs2195OF44oUPj50E0RTt8smcpPDERmXMoHQfslBVhJkJYOsJmh_rLQM1BxPF2dJnjJlnXo7Kf3U8XS16rFqtotjvZNEdlTm8oE-ThAfa66p9L8_-Tmpm_SDHXZwVGuvbjoJ4aLwThq8_ENQv_HXi7ouIFqdoHpNMccCQCS-_qRdXAyE4sRLwXuqZPt_W7yDXlBICwFsXrGLNvvrG_vJO2u93htG4x56dvj1--zsDnlcQeo |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9sgEEdVKm2TpmnrvrJPJu2xboMN2DxW1ap0bfKyRuobAgNqqs2Navch--vHGbCateqk-RE4G3PHcQd3PxD6qgQ1jjGTKWfqjNKJyQBUPXPGGqN5VXMGicKzOZ8u6Pdzdr6FDlMuDIRVRt0fdHqvrWPJfhzN_dVyCTm-AsxpBlGQpAJM0G3KvE4eoe2D45PpfDhMIHwSwJgFyYAggQ_1YV7rlV91vJ-Y0z7cDq7Mvn-BumuA_h1HeWthOnqOnkWLEh-ETr9AW7bZQY9m8cx8Bz0NO3M4JBy9RL9vcQTHMC1su4vGt-_WuzjtYGLVGPzLdmDVLhsMAbNJw7TYFyz2fuzhOuSXdGscEioxdNJe4wjX2mLY58Vpg_cVWhx9OzucZvEGhqymRdlluWDK5BPtVEk0z0VFC_8oP-6O544KnTtTcmG8OGpjrVO5rmvv4NmJhkpRvEaj5qqxbxHWTDOiLGG6ErSmpebam8rCcUUK7yK6McrTsMs6wpPDLRk_ZYpDu5Q9ryTwSgZejdHuQLQK6BwPN6eJnzIlnnpVKf3q8TBZeR-ZbeN0byWRbS4n8o5IjhEfKDek-t-f_JLETfr5Doc4qrFXN60Ej1F4Ow1e_iaI3_DrRVUV4LCOUbUhmEMDwBLfrGmWFz2mOPFc8MYqefe_Pf6MHk_PZqfy9Hh-8h49gZoQJ_kBjbrrG_vR226d_hTn5h9DJESa |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+ethnicity%2C+language+and+metformin+prescriptions+in+U.S.+community+health+center+patients+with+diabetes&rft.jtitle=Preventive+medicine&rft.au=Ezekiel-Herrera%2C+David&rft.au=Marino%2C+Miguel&rft.au=Lucas%2C+Jennifer+A&rft.au=Datta%2C+Roopradha&rft.date=2024-08-01&rft.issn=1096-0260&rft.eissn=1096-0260&rft.volume=185&rft.spage=108025&rft_id=info:doi/10.1016%2Fj.ypmed.2024.108025&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-7435&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-7435&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-7435&client=summon |